These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8363993)

  • 1. Pharmacology, toxicology and human pharmacokinetics of tropisetron.
    Kutz K
    Ann Oncol; 1993; 4 Suppl 3():15-8. PubMed ID: 8363993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the 5HT3 receptor antagonist tropisetron in children.
    Gaedicke G; Erttmann R; Henze G; Hartmann W; Drechsler S; Grass P; Faerber L; Kutz K
    Pediatr Hematol Oncol; 1996; 13(5):405-16. PubMed ID: 10897812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
    Simpson K; Spencer CM; McClellan KJ
    Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological review of tropisetron].
    Yokoyama T
    Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):219-26. PubMed ID: 10584235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.
    Lee CR; Plosker GL; McTavish D
    Drugs; 1993 Nov; 46(5):925-43. PubMed ID: 7507039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic investigation of 5-day multiple dose of tropisetron capsule in patients who had received cisplatin and the usefulness of tropisetron capsule in the treatment of nausea and vomiting].
    Suminaga M; Akasaka Y; Nukariya N; Kimura A; Ohtawa M
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1209-21. PubMed ID: 7544965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?
    Gan TJ
    CNS Drugs; 2005; 19(3):225-38. PubMed ID: 15740177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.
    Kaiser R; Sezer O; Papies A; Bauer S; Schelenz C; Tremblay PB; Possinger K; Roots I; Brockmöller J
    J Clin Oncol; 2002 Jun; 20(12):2805-11. PubMed ID: 12065557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
    Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists.
    Wolf H
    Scand J Rheumatol Suppl; 2000; 113():37-45. PubMed ID: 11028830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediation by 5-HT3 receptors of an excitatory effect of 5-HT on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.
    Wang Y; Ramage AG; Jordan D
    Br J Pharmacol; 1996 Aug; 118(7):1697-704. PubMed ID: 8842434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
    Watson JW; Gonsalves SF; Fossa AA; McLean S; Seeger T; Obach S; Andrews PL
    Br J Pharmacol; 1995 May; 115(1):84-94. PubMed ID: 7544198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions associated with 5- hydroxytryptamine(3)-receptor antagonists: a class effect?
    Kataja V; de Bruijn KM
    Lancet; 1996 Mar; 347(9001):584-5. PubMed ID: 8596322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male/female differences in drug-induced emesis and motion sickness in Suncus murinus.
    Matsuki N; Wang CH; Okada F; Tamura M; Ikegaya Y; Lin SC; Hsu YN; Chaung LJ; Chen SJ; Saito H
    Pharmacol Biochem Behav; 1997 Aug; 57(4):721-5. PubMed ID: 9258999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers.
    Li SX; Pequignot E; Panebianco D; Lupinacci P; Majumdar A; Rosen L; Ahmed T; Royalty JE; Rushmore TH; Murphy MG; Petty KJ
    J Clin Pharmacol; 2006 Jul; 46(7):792-801. PubMed ID: 16809805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of 5-HT3 receptor antagonists and anti-emetic mechanisms of action.
    Freeman AJ; Cunningham KT; Tyers MB
    Anticancer Drugs; 1992 Apr; 3(2):79-85. PubMed ID: 1525396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
    Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
    J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers].
    Alon E; Biro P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 May; 31(4):200-4. PubMed ID: 8704077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.